EMN Stock Recent News

While EMN faces headwinds from weak demand in certain markets, it benefits from cost management, pricing actions and innovation.

KINGSPORT, Tenn.--(BUSINESS WIRE)--Eastman CFO Willie McLain will address the J.P. Morgan Industrials Conference on March 11, 2025, at 11:15 a.m. ET.

EMN's Q4 earnings beat estimates driven by higher sales/volume mix and selling prices.

Eastman Chemical Company (NYSE:EMN ) Q4 2024 Earnings Conference Call January 31, 2025 8:00 AM ET Company Participants Greg Riddle - IR Mark Costa - Board Chair and CEO William McLain - EVP and CFO Emily Alexander - IR Conference Call Participants James Cannon - UBS David Begleiter - Deutsche Bank Mike Sison - Wells Fargo Aleksey Yefremov - KeyCorp Vincent Andrews - Morgan Stanley Frank Mitsch - Fermium Research Jeff Zekauskas - JPMorgan Patrick Cunningham - Citigroup Salvator Tiano - Bank of America Michael Leithead - Barclays Arun Viswanathan - RBC John Roberts - Mizuho Operator Good day, everyone, and welcome to the Fourth Quarter and Full-Year 2024 Eastman Conference Call. Today's conference is being recorded.

Although the revenue and EPS for Eastman Chemical (EMN) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Eastman Chemical (EMN) came out with quarterly earnings of $1.87 per share, beating the Zacks Consensus Estimate of $1.58 per share. This compares to earnings of $1.31 per share a year ago.

KINGSPORT, Tenn.--(BUSINESS WIRE)--Eastman Chemical Company (NYSE:EMN) has announced its fourth-quarter and full-year 2024 financial results.

DuPont (DD), Eastman Chemical (EMN), Avient (AVNT) and Albemarle (ALB) are likely to have benefited from cost and productivity actions amid soft demand in Q4.

EMN is expected to have benefited from cost-cutting and productivity initiatives, as well as its innovation-driven growth strategy in Q4.

Eastman Chemical has underperformed recently but shows promise with improved valuation and strategic direction, making it a conservative "Buy" for 2025. The company's strong fundamentals, diverse product portfolio, and focus on sustainability, especially in molecular recycling, position it well for future growth. Despite recent declines, Eastman's operational improvements, share buybacks, and favorable macro trends suggest significant upside potential, with expected earnings growth in the coming years.